Belzutifan for patients with Von Hippel-Lindau (VHL) disease-associated heterogeneous tumors – a retrospective single center analysis | BMC Cancer

Patients

The Freiburg VHL Center has provided care for VHL patients since 1992 and is one of the largest centers in Germany. Our center currently provides active care for at least 500 patients, with approximately 300 patients seen each year. In…

Continue Reading